… Meta-regression controlling for post-bronchodilator percentage of tFEV 1 predicted at
baseline as well as meta-regression adjusting for concomitant use of inhaled corticosteroids at …

… play equally relevant roles to predict the individual risk and the … with bronchodilator drugs is
the most widely used treatment, … (either in a long-acting beta-agonist (LABA) plus long-acting …

… , the patients included in these studies did not receive any long-acting bronchodilators. …
between 25 and 60% of the predicted value after bronchodilators) who have experienced at least …

… essential role in stable COPD therapy. Long-acting inhaled bronchodilators have been
demonstrated … Our patients’ FEV1 was 45% predicted, while Feldmen’s study FEV1 was 59.6% …

… therapy with inhaled LAMA/LABAs versus treatment with … 2015 (n = 27,172 patients with
stable COPD without an acute or … levels can predict better responses to ICS treatment [Citation38…

… treatment in patients with stable COPD [7]. Similar results were reported after treatment with
a long-acting … that acute bronchodilator responsiveness at baseline did not predict long-term …

… for COPD treatment are long-acting or ultra-long-acting β2-… blood eosinophil counts may
predict COPD exacerbation risk … , bronchodilators are the mainstay of COPD treatment. Adding …

… Baseline COPD characteristics were similar between beta-blocker users and non-users in
terms of post-bronchodilator FEV 1 (mean % predicted, standard deviation [SD] 47.2 [14.2] vs …

… the PREDICT cohort are outlined in Fig. 1. First, we identified all patients who were dispensed
a long-acting bronchodilator … patients who were dispensed a long-acting bronchodilator …

… of emphysema on CT scan in the majority of the patients (81.1… -bronchodilator FEV 1 of 58%
predicted (48–67% predicted). … with inhaled corticosteroids and long-acting β 2 -agonists at …